Jeffrey Tomalka

1.1k total citations
16 papers, 822 citations indexed

About

Jeffrey Tomalka is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jeffrey Tomalka has authored 16 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Jeffrey Tomalka's work include COVID-19 Clinical Research Studies (5 papers), Immune Response and Inflammation (3 papers) and Immune responses and vaccinations (3 papers). Jeffrey Tomalka is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Immune Response and Inflammation (3 papers) and Immune responses and vaccinations (3 papers). Jeffrey Tomalka collaborates with scholars based in United States, Georgia and South Africa. Jeffrey Tomalka's co-authors include Krupen Patel, Amy G. Hise, Katherine A. Fitzgerald, Sandhya Ganesan, Gordon D. Brown, Rafick‐Pierre Sékaly, Mehul S. Suthar, Parameswaran Ramakrishnan, Steven G. Deeks and Chris R. Cardwell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and The Journal of Immunology.

In The Last Decade

Jeffrey Tomalka

16 papers receiving 814 citations

Peers

Jeffrey Tomalka

MB

IMMUN

ID

EPIDE

MICRO

Matheswaran Kandasamy Singapore

Kazuki Tawaratsumida United States

Delphine Cayet France

Hernán F. Peñaloza Chile

Gregory A. Wasserman United States

Kwang–Kyu Kim South Korea

Ji Won Jung South Korea

Martin A. Bewley United Kingdom

Annaliza J. Legaspi United States

Jeffrey J. Bunker United States

Matheswaran Kandasamy Singapore

Jeffrey Tomalka

467 ×1.2

MB

459 ×1.2

IMMUN

188 ×0.6

ID

275 ×1.1

EPIDE

48 ×0.7

MICRO

Citations per year, relative to Jeffrey Tomalka Jeffrey Tomalka (= 1×) peers Matheswaran Kandasamy

Countries citing papers authored by Jeffrey Tomalka

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Tomalka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Tomalka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Tomalka more than expected).

Fields of papers citing papers by Jeffrey Tomalka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Tomalka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Tomalka. The network helps show where Jeffrey Tomalka may publish in the future.

Co-authorship network of co-authors of Jeffrey Tomalka

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Tomalka. A scholar is included among the top collaborators of Jeffrey Tomalka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Tomalka. Jeffrey Tomalka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Collins, Jeffrey M., Maia Kipiani, Ashish Sharma, et al.. (2025). Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. PLoS ONE. 20(3). e0315999–e0315999. 1 indexed citations

2.

Tomalka, Jeffrey, Anna H. Owings, Carly G.K. Ziegler, et al.. (2025). Enhanced Production of Lipid Mediators in Plasma and Activation of DNA Damage Pathways in PBMCs Are Correlated With the Severity of Ancestral SARS ‐ CoV ‐2 Infection. The FASEB Journal. 39(9). e70600–e70600. 1 indexed citations

3.

Tomalka, Jeffrey, Ashish Sharma, Alison Smith, et al.. (2023). Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks. Tuberculosis. 144. 102462–102462. 8 indexed citations

4.

Tomalka, Jeffrey, Mehul S. Suthar, Steven G. Deeks, & Rafick‐Pierre Sékaly. (2022). Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses. Nature Immunology. 23(3). 360–370. 36 indexed citations

5.

Tomalka, Jeffrey, Mehul S. Suthar, Michael Diamond, & Rafick‐Pierre Sékaly. (2022). Innate antiviral immunity: how prior exposures can guide future responses. Trends in Immunology. 43(9). 696–705. 16 indexed citations

6.

Tomalka, Jeffrey, et al.. (2021). Negative regulation of FOXP3 expression by c-Rel O-GlcNAcylation. Glycobiology. 31(7). 812–826. 18 indexed citations

7.

Sékaly, Rafick‐Pierre, et al.. (2021). Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines. Current Opinion in Virology. 52. 89–101. 3 indexed citations

8.

Tashtish, Nour, Binita Shah, Jeffrey Tomalka, et al.. (2020). Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults. SHILAP Revista de lepidopterología. 5(1). 312–312. 15 indexed citations

9.

Tashtish, Nour, Binita Shah, Jeffrey Tomalka, et al.. (2020). Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults. 5(1). 312–312. 3 indexed citations

10.

Tomalka, Jeffrey, et al.. (2016). Sam68 is a regulator of Toll-like receptor signaling. Cellular and Molecular Immunology. 14(1). 107–117. 16 indexed citations

11.

Tomalka, Jeffrey, Khader Ghneim, Malika Aïd, et al.. (2016). The sooner the better: innate immunity as a path toward the HIV cure. Current Opinion in Virology. 19. 85–91. 7 indexed citations

12.

Ramakrishnan, Parameswaran, Mary A. Yui, Jeffrey Tomalka, et al.. (2016). Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice. Diabetes. 65(8). 2367–2379. 18 indexed citations

13.

Tomalka, Jeffrey, Hema P. Narra, Krupen Patel, et al.. (2015). β-Defensin 1 Plays a Role in Acute Mucosal Defense against Candida albicans. The Journal of Immunology. 194(4). 1788–1795. 70 indexed citations

14.

Tomalka, Jeffrey. (2013). Mucosal Immune Defenses to the Fungal Pathogen Candida albicans. 1 indexed citations

15.

Tomalka, Jeffrey, et al.. (2011). A Novel Role for the NLRC4 Inflammasome in Mucosal Defenses against the Fungal Pathogen Candida albicans. PLoS Pathogens. 7(12). e1002379–e1002379. 143 indexed citations

16.

Hise, Amy G., Jeffrey Tomalka, Sandhya Ganesan, et al.. (2009). An Essential Role for the NLRP3 Inflammasome in Host Defense against the Human Fungal Pathogen Candida albicans. Cell Host & Microbe. 5(5). 487–497. 466 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact